Information PortalData PortalKnowledge Portal

Data Matrix

Tools & Workflows

Documentation

2928.02 (Glytoucan)

Id:03274989-b3e2-5d6c-b133-5aa7d6c2eb95

Glytoucan:G11815LC

Results found

Linked to

	Label	Description
	2928.02 has glycosequence GLYGEN.GLYCOSEQUENCE:G05060ST-GLYCOSEQ00171155 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2928.02 has glycosequence GLYGEN.GLYCOSEQUENCE:G15391CM-GLYCOSEQ00042391 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2928.02 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000107 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2928.02 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000055 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2928.02 has glycosequence GLYGEN.GLYCOSEQUENCE:G89721KZ-GLYCOSEQ00098845 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2928.02 has glycosequence GLYGEN.GLYCOSEQUENCE:G71974QQ-GLYCOSEQ00047696 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2928.02 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000011 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2928.02 has canonical residue n-glycan core b-d-glcpnac b Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2928.02 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000021 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2928.02 has glycosequence GLYGEN.GLYCOSEQUENCE:G15391CM-GLYCOSEQ00042392 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2928.02 has glycosequence GLYGEN.GLYCOSEQUENCE:G05060ST-GLYCOSEQ00171155 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2928.02 has glycosequence GLYGEN.GLYCOSEQUENCE:G15391CM-GLYCOSEQ00042391 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2928.02 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000107 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2928.02 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000055 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2928.02 has glycosequence GLYGEN.GLYCOSEQUENCE:G89721KZ-GLYCOSEQ00098845 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2928.02 has glycosequence GLYGEN.GLYCOSEQUENCE:G71974QQ-GLYCOSEQ00047696 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2928.02 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000011 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2928.02 has canonical residue n-glycan core b-d-glcpnac b

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2928.02 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000021 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2928.02 has glycosequence GLYGEN.GLYCOSEQUENCE:G15391CM-GLYCOSEQ00042392 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.